… and staging of prostate cancer. An accurate … systematic review, we aim to update the
current available evidence of the role of 18 F-FCH PET in various aspects of prostate cancer…

… 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a
systematic review and meta-analysis … Regarding imaging, recent guidelines for prostate cancer …

… Diagnostic accuracies of positron emission tomography/computed tomography and
conventional imaging in patients with prostate cancer in different settings of disease …

… Prostate cancer (PCa) is the most common cancer in males and the second most common
cause of death from cancer in developed countries. In 2018, an estimated 164,690 males will …

… /CT, 18F-fluorocholine PET/CT … Prostate cancer patients were prospectively included
between December 2011 and August 2014 and benefited from these three whole-body imaging (…

… This comparative study demonstrates an overall superior performance of [ 68 Ga]Ga-PSMA
compared to [ 18 F]Fluorocholine for PET/CT imaging in prostate cancer patients referred for …

… patients with inconclusive conventional imaging: a multicenter study from the Netherlands. …
The PET/CT test with 18 F-fluorocholine was initially used as a tracer in prostate cancer. The …

… We performed a systematic review of the literature using MEDLINE and Web of … systematic
review of currently available imaging modalities to stage newly diagnosed prostate cancer…

… 18F-fluorocholine is a specific promising agent for imaging … reviews the value of 18F-NaF
PET/CT and 18Ffluorocholine PET/CT in the assessment of bone metastases in prostate cancer…

… (PSMA)-11 for the imaging of patients with PSMA-positive prostate cancer (PCa) in cases
of … In the current study, we investigated the diagnostic efficacy of 18F-Fluorocholine PET/CT …